Pharmacological studies of a new antiinflammatory compound, 2-phenyl-6-dimethylamino-6H-cycloheptoxazole.
D000632:Aminopyrine / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002351:Carrageenan / Q000037:antagonists & inhibitors; D002725:Chloroform / Q000037:antagonists & inhibitors; D003516:Cycloparaffins / Q000494:pharmacology*; D003911:Dextrans / Q000037:antagonists & inhibitors; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control*; D004890:Erythema / Q000517:prevention & control; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology; D005461:Fluorine / Q000494:pharmacology; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006821:Hyaluronoglucosaminidase / Q000037:antagonists & inhibitors; D007616:Kaolin / Q000037:antagonists & inhibitors; D008297:Male; D051379:Mice; D010539:Permeability; D010653:Phenylbutazone / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D011837:Radiation-Protective Agents / Q000494:pharmacology; D051381:Rats; D012702:Serotonin Antagonists; D012867:Skin / Q000187:drug effects; D014466:Ultraviolet Rays; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D003516:Cycloparaffins; D003911:Dextrans; D006634:Histamine H1 Antagonists; D011837:Radiation-Protective Agents; D012702:Serotonin Antagonists; D062367:ortho-Aminobenzoates; D000632:Aminopyrine; D007616:Kaolin; D005461:Fluorine; D005439:Flufenamic Acid; D002725:Chloroform; D002351:Carrageenan; D011239:Prednisolone; D006821:Hyaluronoglucosaminidase; D010653:Phenylbutazone; D001241:Aspirin; D001920:Bradykinin